Classification:
Title:
Apixaban
CAS NO.：
503612-47-3
Summary:
GMP
Description:
Apixaban is an oral anticoagulant used to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). It works by selectively inhibiting factor Xa, a key enzyme in the blood coagulation pathway, reducing the risk of stroke and systemic embolism. Apixaban is preferred for its predictable effect, lower risk of major bleeding, and convenience of fixed dosing without routine monitoring. It is widely used in clinical practice for long-term thromboprophylaxis.It is also effective in patients with high cardiovascular risk, improving overall safety and treatment outcomes.
Keywords:
Salcaprozate Sodium（SNAC）
Sodium Decanoate/Sodium Caprate（C10）
Potassium decanoate
N-(5-chlorosalicyloyl)-8-aminocaprylic acid（5-CNAC）（ 1:1 ）、（ 1:2 ）
10-(2-Hydroxybenzamido)decanoic acid (SNAD) (1:1) 、（1:2）
Sodium; 7-(2-hydroxy-benzoylamino)-heptanoate (SNAG)
Similar related products
The products supplied by the company are only used for research and development. Except for the approval of the competent authority, it is strictly prohibited to be used in the production and sales of medicines, food and health products.
NO.
Name
CAS
Abstract
More
